Regulatory Webcast RECORDING: Biomarker Strategies and Implementation in Drug Development

(Recorded live on Tuesday, July 14, 2020)

Biomarkers are important tools for successful biopharmaceutical-targeted drug development and regulatory approval. Biomarkers can be diagnostic and/or prognostic, indicative of precision drug targeting. As such, biomarkers are increasingly used to characterize disease and monitor treatment performance, enrich responsive patient enrollment in clinical trials, and support regulatory approval process and labeling.

Biomarker assay development should start early in the drug development cycle, and its timing needs to be carefully crafted upon individual development phases. This co-development process can be a particular challenge for emerging biotech companies with limited funds and resources and requires decisions to be made on how to optimize and advance biomarker assay development to support preclinical or clinical development. Other considerations include the challenging decision point of when to transition the assay into companion diagnostic development, which comes with additional regulatory requirements.

With Suzana Corritori, MD, Ph.D., MSc and Flagship COO, Meredith James, for this webinar to learn practical considerations and guidance for emerging biotech companies to navigate through successful biomarker strategy implementation into multi-faceted drug development and regulatory approval.

Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

Recent Posts

2024 ASGCT Annual Meeting

Are you attending the 2024 ASGCT Annual Meeting?With field-leading keynotes, 200+ scientific sessions, over 7,000 researchers in attendance, and an expanded exhibit hall, the 27th American Society of Gene and Cell Therapy Annual Meeting is the nexus for gene and cell...

AACR Annual Meeting 2024

Meet with us at the AACR Annual Meeting 2024 to learn about our spatial biology solutions. Flagship Biosciences is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the...

Spatial Biology for Immuno-Oncology Summit 2024

Meet with us at the Spatial Biology for Immuno-Oncology Summit.The Spatial Biology for Immuno-Oncology Summit is back for its second year, and Flagship Biosciences is a Program Partner for the event. Join us January 23-25 in San Diego where key industry leaders will...

65th ASH Annual Meeting and Exposition

Meet with us at the American Society of Hematology annual meeting in December. Whether you’re engaged in basic research or drug development, our genomics solutions offer valuable insights to help you achieve your goals. We offer the highest quality results and support...

Society for Immunotherapy of Cancer Annual Meeting

Visit Flagship at SITC 2023 Booth #716. November 3-5, 2023. We offer a comprehensive set of discovery, translational and clinical testing, and assay development services to support your clinical studies in immune-oncology and immunotherapy. From the selection of...